Search
for

    Sort by

    Research 30 of 1000+

    1. Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice Cancer Research · 2009 · 53 citations
    2. IL-1 alpha inhibits human hair follicle growth and hair fiber production in whole-organ cultures. PubMed · 1993 · 30 citations
    3. A Comparison of Varying alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms. PubMed · 2005 · 52 citations
    4. 증례 : 순환기 ; 독사조신 복용 후 발생한 여성형유방증 1예 The Korean Journal of Internal Medicine · 2016
    5. Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review Curēus · 2023 · 1 citations
    6. Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia Frontiers in Pharmacology · 2020 · 35 citations
    7. Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia Current Medicinal Chemistry · 2006 · 14 citations
    8. Cognitive and mood side effects of lower urinary tract medication Expert Opinion on Drug Safety · 2019 · 20 citations
    9. Inhibitors of 5α-Reductase in the Treatment of Benign Prostatic Hyperplasia Current pharmaceutical design · 2006 · 52 citations
    10. 17β-estradiol Inhibits the Production of RANTES in Human Keratinocytes Journal of Investigative Dermatology · 2003 · 56 citations
    11. Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib ACG Case Reports Journal · 2021 · 2 citations
    12. Development of an aequorin-based assay for the screening of corticotropin-releasing factor receptor antagonists Journal of the Korea Academia-Industrial cooperation Society · 2015
    13. Тіе Modern treatment of androgenetic alopecia Vestnik dermatologii i venerologii · 2017
    14. Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands 2009 · 36 citations
    15. Adverse Effects and Drug Interactions of Biologic Agents Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2010
    16. Androgens inhibit phagocytosis by macrophages via the androgen receptor in vitro 2026
    17. Current treatment of BPH Biomedicine & pharmacotherapy · 1995 · 11 citations
    18. Molecular Interactions of New Pregnenedione Derivatives Chemical and Pharmaceutical Bulletin · 2003 · 20 citations
    19. Medikamentöse Therapie des benignen Prostatasyndroms mit α1-Rezeptorblockern Grundlagen und klinische Ergebnisse Der Urologe · 2002 · 22 citations
    20. Intraoperative floppy iris syndrome Current Opinion in Ophthalmology · 2008 · 41 citations
    21. Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances Current Medicinal Chemistry · 2004 · 153 citations
    22. Risk factors for intraoperative floppy iris syndrome: One year prospective study Acta Ophthalmologica · 2013
    23. Тіе Modern treatment of androgenetic alopecia DOAJ (DOAJ: Directory of Open Access Journals) · 2017
    24. New treatments for rheumatoid arthritis Postgraduate Medicine · 1999 · 13 citations
    25. Lower urinary tract symptoms (LUTS): The role of medications in improvement of quality of life Galenika Medical Journal · 2022
    26. Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens Journal of Medicinal Chemistry · 1995 · 12 citations
    27. A Role for Steroid 5 alpha-reductase 1 in Vascular Remodelling During Endometrial Decidualisation bioRxiv (Cold Spring Harbor Laboratory) · 2022
    28. Injury-induced interleukin-1 alpha promotes Lgr5 hair follicle stem cells de novo regeneration and proliferation via regulating regenerative microenvironment in mice Inflammation and Regeneration · 2023 · 7 citations
    29. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1 Endocrine Practice · 2015 · 343 citations
    30. Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS) The Aging Male · 2026